"Designing Growth Strategies is in our DNA"

Chronic Myeloid Leukemia Treatment Market Size, Share & Industry Analysis, By Type (Targeted Therapy, Chemotherapy, Immunotherapy, Stem Cell Therapy), By End-User (Hospitals, Speciality Clinics, Others) and Regional Forecast, 2019-2026

Region : Global | Report ID: FBI103094 | Status : Ongoing

 

KEY MARKET INSIGHTS

The chronic myeloid leukemia treatment market is growing due to the increase in the incidences and prevalence of CML, growing awareness towards CML, and escalation in the R&D activities. According to the American Cancer Society 2019, CML accounts for 10 -15% of all leukemia cases and about 1 in 526 people is likely to be affected with CML in their lifetime in the United States. Chronic myeloid leukemia (CML) is also known as chronic myelocytic, myelogenous, or non-lymphocytic leukemia.  CML is a type of cancer that affects certain blood-forming cells of the bone marrow. CML is expected to take a long time prior to show problems, and people live in this condition for long time even before they know it. However, chronic leukemias are usually difficult and complicated to cure than acute leukemias.


Increase in the prevalence of chronic myeloid leukemia is the major factors motivating the growth of the market. According to the World Cancer Research Fund International 2018, leukemia accounts for 2.6% of all the cancer cases globally. This rising incidence and increase in the prevalence is likely to propel the market in the forecast period. Also, the rising awareness about cancer, technological advances, expansion of research and development, and launch of novel therapies to treat CML are likely to boost the market growth


However, high cost of chronic myeloid leukemia treatment and side effects related to the treatment are impeding the growth of the market.


Key Market Driver -

Increase in the prevalence of chronic myeloid leukemia and expansion in the research & development activities are boosting the market growth

Key Market Restraint -

The high cost and side effects associated with treatment are likely to hinder the market growth.


Market Segmentation:


Globally, the chronic myeloid leukemia treatment market can be segmented on the basis of type, end-users, and region. Based on the type, the market can be segmented into targeted therapy, chemotherapy, immunotherapy, and stem cell therapy. Based on the end-users the market can be segmented into hospitals, speciality clinics, and others.


Geographically, the chronic myeloid leukemia treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the chronic myeloid leukemia treatment market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Bristol-Myers Squibb Company, Incyte, Biopath Holdings Inc., Stragen Pharma SA, Otsuka Holdings Co., Ltd., Takeda Pharmaceutical Company Limited and other prominent players.


Key Insights:



  • Prevalence of Chronic Myeloid Leukemia by Key Countries/Region, 2018

  • Technological Advancements by Key Countries/Region, 2018

  • Introduction of New Products/Approvals (By Major Players)

  • Key Industry Developments Mergers, Acquisitions, and Collaborations


Regional Analysis:


To gain extensive insights into the market, Request for Customization


Geographically, the chronic myeloid leukemia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North American region is expected to hold the significant share of the market and is anticipated to follow the same thrust over the forecast period. The growth of the market in this region can be recognized due to the presence of advanced healthcare infrastructure along with rising alertness regarding leukemia. Moreover, increase in the prevalence of the chronic myeloid leukemia (CML) increasing availability & growing adoption of technologically advanced products are also propelling the market in this region. Europe is anticipated to hold the second largest share of the market in the forecast period. The factors such as increase in the prevalence of the CML, rising healthcare expenditure by European Commission and increasing new product launches are likely to boost the growth of the CML treatment market in this region. On the other hand, Asia-Pacific is likely to register and enjoy the highest market growth in the forecast period. The overall growth of the market can be attributed to the increase in the incidence of the CML, increase in the purchasing power of the countries, tendency to adopt innovative therapies and satisfactory insurance policies are the major factors driving the growth of the market in this region. The market in Latin America and the Middle East and Africa are estimated to grow fairly in the forecast period. The growing healthcare expenditure and geographical expansion of key players in the region are responsible for the growth of the market.


Segmentation






















 ATTRIBUTE


  DETAILS

By Type




  • Targeted Therapy

  • Chemotherapy

  • Immunotherapy

  • Stem Cell Therapy



By End-User




  • Hospitals

  • Speciality Clinics

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Chronic Myeloid Leukemia Treatment Market Industry Developments



  • In December 2018, Bristol-Myers Squibb Company received positive CHMP opinion recommending sprycel (dasatinib) for paediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia as well as for children suffering from cml

  • In January 2017, Takeda Pharmaceutical Company Limited acquired ARIAD Pharmaceuticals, Inc. This acquisition transformed company’s global oncology portfolio.


Chronic Myeloid Leukemia Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

lpsos
novo-nordisk
DUPONT
Ge-Healthcare
chong-kun-dang

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X